Praxis Precision Medicines Inc (PRAX)
72.59
+2.60
(+3.71%)
USD |
NASDAQ |
Nov 05, 16:00
74.68
+2.09
(+2.88%)
After-Hours: 20:00
Praxis Precision Medicines Enterprise Value: 890.94M for Nov. 4, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
November 04, 2024 | 890.94M |
November 01, 2024 | 861.46M |
October 31, 2024 | 890.94M |
October 30, 2024 | 891.56M |
October 29, 2024 | 909.41M |
October 28, 2024 | 921.84M |
October 25, 2024 | 918.46M |
October 24, 2024 | 900.17M |
October 23, 2024 | 934.45M |
October 22, 2024 | 931.07M |
October 21, 2024 | 946.70M |
October 18, 2024 | 947.94M |
October 17, 2024 | 978.48M |
October 16, 2024 | 963.21M |
October 15, 2024 | 927.52M |
October 14, 2024 | 891.83M |
October 11, 2024 | 802.33M |
October 10, 2024 | 748.53M |
October 09, 2024 | 767.53M |
October 08, 2024 | 798.25M |
October 07, 2024 | 757.76M |
October 04, 2024 | 801.27M |
October 03, 2024 | 825.42M |
October 02, 2024 | 733.79M |
October 01, 2024 | 667.91M |
Date | Value |
---|---|
September 30, 2024 | 669.86M |
September 27, 2024 | 675.01M |
September 26, 2024 | 674.30M |
September 25, 2024 | 682.47M |
September 24, 2024 | 697.03M |
September 23, 2024 | 652.28M |
September 20, 2024 | 740.36M |
September 19, 2024 | 767.17M |
September 18, 2024 | 702.54M |
September 17, 2024 | 673.06M |
September 16, 2024 | 683.18M |
September 13, 2024 | 711.42M |
September 12, 2024 | 690.46M |
September 11, 2024 | 676.97M |
September 10, 2024 | 701.47M |
September 09, 2024 | 695.61M |
September 06, 2024 | 607.36M |
September 05, 2024 | 696.50M |
September 04, 2024 | 726.15M |
September 03, 2024 | 631.51M |
August 30, 2024 | 591.91M |
August 29, 2024 | 589.96M |
August 28, 2024 | 554.80M |
August 27, 2024 | 598.48M |
August 26, 2024 | 572.02M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-142.87M
Minimum
Jun 09 2022
2.253B
Maximum
Dec 28 2020
439.09M
Average
367.40M
Median
Jul 28 2021
Enterprise Value Benchmarks
Exelixis Inc | 8.603B |
Ionis Pharmaceuticals Inc | 5.257B |
Assembly Biosciences Inc | -6.040M |
Marinus Pharmaceuticals Inc | 10.41M |
Protagonist Therapeutics Inc | 2.190B |
Enterprise Value Related Metrics
Net Income (Quarterly) | -32.68M |
Revenue (Quarterly) | 0.357M |
Total Expenses (Quarterly) | 37.84M |
EPS Diluted (Quarterly) | -1.74 |
Profit Margin (Quarterly) | -9.15K% |
Earnings Yield | -12.63% |
Normalized Earnings Yield | -12.63 |